Lumbosacral Radicular Pain Management Global Market Report 2025

Description

Lumbosacral radicular pain management involves a comprehensive strategy for diagnosing, treating, and alleviating pain caused by irritation or compression of the spinal nerve roots in the lumbosacral region (lower back and sacral area). This condition is often linked to issues such as herniated discs, spinal stenosis, or degenerative disc disease. Treatment focuses on reducing inflammation, relieving pressure on the affected nerves, and supporting functional recovery. The primary goal is to improve mobility, reduce pain, and enhance the patient's overall quality of life.

The key categories of medications used in managing lumbosacral radicular pain include non-steroidal anti-inflammatory drugs (NSAIDs), opioids, antidepressants, anticonvulsants, and steroids. NSAIDs are commonly used as a first-line treatment to alleviate pain and inflammation by blocking the enzymes responsible for inflammation. Management may also involve various physical therapies, including manual therapy, exercise therapy, electrotherapy, thermal therapy, and hydrotherapy. These treatments are delivered through different routes, such as oral and topical administration, and are made available through multiple distribution channels, including hospital pharmacies, retail pharmacies, and online pharmacies.

The lumbosacral radicular pain management market research report is one of a series of new reports from The Business Research Company that provides lumbosacral radicular pain management market statistics, including the lumbosacral radicular pain management industry global market size, regional shares, competitors with the lumbosacral radicular pain management market share, detailed lumbosacral radicular pain management market segments, market trends, opportunities, and any further data you may need to thrive in the lumbosacral radicular pain management industry. This lumbosacral radicular pain management market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The lumbosacral radicular pain management market size has grown strongly in recent years. It will grow from $0.85 billion in 2024 to $0.90 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth during the historic period can be attributed to the increasing prevalence of lumbar disc herniation, heightened awareness of spinal disorders, a growing elderly population, advancements in diagnostic imaging technologies, and the broader adoption of non-invasive pain management therapies.

The lumbosacral radicular pain management market size is expected to see strong growth in the next few years. It will grow to $1.11 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The anticipated growth in the forecast period can be attributed to innovations in minimally invasive surgical techniques, the rising adoption of biologic therapies, an increasing emphasis on personalized pain management, growing demand for outpatient pain clinics, and the integration of digital health and telemedicine into pain management practices. Key trends expected during this period include progress in minimally invasive spine surgeries, advancements in neurostimulation devices, the use of biologic therapies such as platelet-rich plasma, the application of AI-driven diagnostics and personalized treatment strategies, and the development of new non-opioid analgesics.

The increasing prevalence of back pain disorders is expected to drive the growth of the lumbosacral radicular pain management market in the coming years. Back pain disorders encompass various conditions affecting the spine, muscles, or nerves in the back, resulting in discomfort or pain. This rise is largely attributed to sedentary lifestyles that weaken back muscles, leading to poor posture and chronic pain. Lumbosacral radicular pain management focuses on alleviating nerve root irritation in the lower back, thereby reducing pain and inflammation, restoring mobility, and enhancing overall quality of life. For example, in June 2024, the Australian Institute of Health and Welfare, a government agency, reported that in 2022, more than half (52%) of hospitalizations for back problems were due to back or spinal pain, with lower back pain accounting for the highest proportion at 27%, followed by neck pain at 6.2% and radiculopathy at 6.0%. Additionally, back problems had become the third leading contributor to the total health burden in 2023, representing 4.3% of the overall impact. As a result, the growing prevalence of back pain disorders is a key factor fueling the expansion of the lumbosacral radicular pain management market.

Leading companies in the lumbosacral radicular pain management market are concentrating on developing advanced therapies, such as investigational oral NaV1.8 pain signal inhibitors, to provide non-opioid options for long-lasting pain relief. These investigational drugs target the NaV1.8 sodium channel, a critical component in transmitting pain signals through sensory nerves. For example, in December 2024, Vertex Pharmaceuticals, a U.S.-based biotechnology company, released results from its Phase 2 clinical trial of suzetrigine for treating painful lumbosacral radiculopathy (LSR). The trial achieved its primary endpoint, demonstrating a statistically significant and clinically meaningful reduction in pain from baseline in patients receiving suzetrigine. The drug was generally well tolerated, with no serious adverse events reported. Vertex plans to address the high placebo response observed in the study in upcoming Phase 3 trials to better evaluate the drug's efficacy.

In October 2024, Stryker Corporation, a U.S.-based medical technology company, acquired Vertos Medical Inc. for an undisclosed amount. Through this acquisition, Stryker seeks to expand its interventional pain management portfolio, increase its footprint in ambulatory surgery centers, and enhance its capabilities in minimally invasive treatments for chronic lower back pain. Vertos Medical Inc. is a U.S.-based company specializing in interventional pain management solutions, particularly the minimally invasive mild(R) procedure for treating lumbar spinal stenosis.

Major players in the lumbosacral radicular pain management market are Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Sanofi SA, Bristol-Myers Squibb, AstraZeneca plc, Novartis AG, GSK plc, Medtronic plc, Eli Lilly and Company, Amgen Inc, Koninklijke Philips NV, Stryker Corporation, Teva Pharmaceutical Industries Ltd, Boston Scientific Corporation, Dr Reddy's Laboratories Ltd, NuVasive Inc., Nobel Biocare Holdings AG, Ultradent Products Inc., Nevro Corp., Zynex Inc., Eliem Therapeutics, Vertebral Technologies Inc., Semnur Pharmaceuticals Inc.

North America was the largest region in the lumbosacral radicular pain management market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in lumbosacral radicular pain management report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the lumbosacral radicular pain management market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The lumbosacral radicular pain management market consists of revenues earned by entities by providing services such as psychological therapy, surgical intervention, chiropractic care, and pharmacological management. The market value includes the value of related goods sold by the service provider or included within the service offering. The lumbosacral radicular pain management market includes sales of muscle relaxants, epidural steroid injections, and nerve blocks. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Lumbosacral Radicular Pain Management Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on lumbosacral radicular pain management market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for lumbosacral radicular pain management ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The lumbosacral radicular pain management market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Medication: Non-Steroidal Anti-Inflammatory Drugs; Opioids; Antidepressants; Anticonvulsants; Steroids
2) By Physical Therapy: Manual Therapy; Exercise Therapy; Electrotherapy; Thermal Therapy; Hydrotherapy
3) By Route Of Administration: Oral; Topical
4) By End-User: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
Subsegments:
1) By Non-Steroidal Anti-Inflammatory Drugs: Ibuprofen; Naproxen; Diclofenac; Celecoxib; Etoricoxib
2) By Opioids: Tramadol; Oxycodone; Morphine; Hydrocodone; Fentanyl
3) By Antidepressants: Amitriptyline; Nortriptyline; Duloxetine; Desvenlafaxine; Venlafaxine
4) By Anticonvulsants: Gabapentin; Pregabalin; Carbamazepine; Lamotrigine; Topiramate
5) By Steroids: Dexamethasone; Methylprednisolone; Prednisone; Triamcinolone; Hydrocortison
Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; Bayer AG; Sanofi SA; Bristol-Myers Squibb
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r35960

1. Executive Summary

2. Lumbosacral Radicular Pain Management Market Characteristics

3. Lumbosacral Radicular Pain Management Market Trends And Strategies

4. Lumbosacral Radicular Pain Management Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Lumbosacral Radicular Pain Management Growth Analysis And Strategic Analysis Framework

5.1. Global Lumbosacral Radicular Pain Management PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Lumbosacral Radicular Pain Management Market Growth Rate Analysis
5.4. Global Lumbosacral Radicular Pain Management Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Lumbosacral Radicular Pain Management Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Lumbosacral Radicular Pain Management Total Addressable Market (TAM)

6. Lumbosacral Radicular Pain Management Market Segmentation

6.1. Global Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Non-Steroidal Anti-Inflammatory Drugs
Opioids
Antidepressants
Anticonvulsants
Steroids
6.2. Global Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Manual Therapy
Exercise Therapy
Electrotherapy
Thermal Therapy
Hydrotherapy
6.3. Global Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Topical
6.4. Global Lumbosacral Radicular Pain Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
6.5. Global Lumbosacral Radicular Pain Management Market, Sub-Segmentation Of Non-Steroidal Anti-Inflammatory Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Ibuprofen
Naproxen
Diclofenac
Celecoxib
Etoricoxib
6.6. Global Lumbosacral Radicular Pain Management Market, Sub-Segmentation Of Opioids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tramadol
Oxycodone
Morphine
Hydrocodone
Fentanyl
6.7. Global Lumbosacral Radicular Pain Management Market, Sub-Segmentation Of Antidepressants, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Amitriptyline
Nortriptyline
Duloxetine
Desvenlafaxine
Venlafaxine
6.8. Global Lumbosacral Radicular Pain Management Market, Sub-Segmentation Of Anticonvulsants, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Gabapentin
Pregabalin
Carbamazepine
Lamotrigine
Topiramate
6.9. Global Lumbosacral Radicular Pain Management Market, Sub-Segmentation Of Steroids, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Dexamethasone
Methylprednisolone
Prednisone
Triamcinolone
Hydrocortisone

7. Lumbosacral Radicular Pain Management Market Regional And Country Analysis

7.1. Global Lumbosacral Radicular Pain Management Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Lumbosacral Radicular Pain Management Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Lumbosacral Radicular Pain Management Market

8.1. Asia-Pacific Lumbosacral Radicular Pain Management Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Lumbosacral Radicular Pain Management Market

9.1. China Lumbosacral Radicular Pain Management Market Overview
9.2. China Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Lumbosacral Radicular Pain Management Market

10.1. India Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Lumbosacral Radicular Pain Management Market

11.1. Japan Lumbosacral Radicular Pain Management Market Overview
11.2. Japan Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Lumbosacral Radicular Pain Management Market

12.1. Australia Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Lumbosacral Radicular Pain Management Market

13.1. Indonesia Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Lumbosacral Radicular Pain Management Market

14.1. South Korea Lumbosacral Radicular Pain Management Market Overview
14.2. South Korea Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Lumbosacral Radicular Pain Management Market

15.1. Western Europe Lumbosacral Radicular Pain Management Market Overview
15.2. Western Europe Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Lumbosacral Radicular Pain Management Market

16.1. UK Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Lumbosacral Radicular Pain Management Market

17.1. Germany Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Lumbosacral Radicular Pain Management Market

18.1. France Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Lumbosacral Radicular Pain Management Market

19.1. Italy Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Lumbosacral Radicular Pain Management Market

20.1. Spain Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Lumbosacral Radicular Pain Management Market

21.1. Eastern Europe Lumbosacral Radicular Pain Management Market Overview
21.2. Eastern Europe Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Lumbosacral Radicular Pain Management Market

22.1. Russia Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Lumbosacral Radicular Pain Management Market

23.1. North America Lumbosacral Radicular Pain Management Market Overview
23.2. North America Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Lumbosacral Radicular Pain Management Market

24.1. USA Lumbosacral Radicular Pain Management Market Overview
24.2. USA Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Lumbosacral Radicular Pain Management Market

25.1. Canada Lumbosacral Radicular Pain Management Market Overview
25.2. Canada Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Lumbosacral Radicular Pain Management Market

26.1. South America Lumbosacral Radicular Pain Management Market Overview
26.2. South America Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Lumbosacral Radicular Pain Management Market

27.1. Brazil Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Lumbosacral Radicular Pain Management Market

28.1. Middle East Lumbosacral Radicular Pain Management Market Overview
28.2. Middle East Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Lumbosacral Radicular Pain Management Market

29.1. Africa Lumbosacral Radicular Pain Management Market Overview
29.2. Africa Lumbosacral Radicular Pain Management Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Lumbosacral Radicular Pain Management Market, Segmentation By Physical Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Lumbosacral Radicular Pain Management Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Lumbosacral Radicular Pain Management Market Competitive Landscape And Company Profiles

30.1. Lumbosacral Radicular Pain Management Market Competitive Landscape
30.2. Lumbosacral Radicular Pain Management Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Bristol-Myers Squibb Overview, Products and Services, Strategy and Financial Analysis

31. Lumbosacral Radicular Pain Management Market Other Major And Innovative Companies

31.1. AstraZeneca plc
31.2. Novartis AG
31.3. GSK plc
31.4. Medtronic plc
31.5. Eli Lilly and Company
31.6. Amgen Inc
31.7. Koninklijke Philips NV
31.8. Stryker Corporation
31.9. Teva Pharmaceutical Industries Ltd
31.10. Boston Scientific Corporation
31.11. Dr Reddy's Laboratories Ltd
31.12. NuVasive Inc.
31.13. Nobel Biocare Holdings AG
31.14. Ultradent Products Inc.
31.15. Nevro Corp.

32. Global Lumbosacral Radicular Pain Management Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Lumbosacral Radicular Pain Management Market

34. Recent Developments In The Lumbosacral Radicular Pain Management Market

35. Lumbosacral Radicular Pain Management Market High Potential Countries, Segments and Strategies

35.1 Lumbosacral Radicular Pain Management Market In 2029 - Countries Offering Most New Opportunities
35.2 Lumbosacral Radicular Pain Management Market In 2029 - Segments Offering Most New Opportunities
35.3 Lumbosacral Radicular Pain Management Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer